Assertio Holdings, Inc. (ASRT)
9.07
-0.13
(-1.41%)
USD |
NASDAQ |
Dec 31, 16:00
9.09
+0.02
(+0.22%)
After-Hours: 20:00
Assertio Holdings Cash from Investing (Quarterly): -3.812M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 13.99M |
| Skye Bioscience, Inc. | 7.967M |
| Theravance Biopharma, Inc. | -100.25M |
| FibroGen, Inc. | 87.16M |
| Myomo, Inc. | 0.1897M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.767M |
| Cash from Financing (Quarterly) | -0.007M |
| Free Cash Flow | 13.33M |
| Free Cash Flow Per Share (Quarterly) | -0.6713 |
| Free Cash Flow to Equity (Quarterly) | -3.948M |
| Free Cash Flow to Firm (Quarterly) | -3.994M |
| Free Cash Flow Yield | 2.87% |